Resection for Multiple Hepatocellular Carcinomas (HCC)
- Conditions
- Hepatocellular CarcinomaMultiple TumorsCirrhosis
- Registration Number
- NCT01387061
- Lead Sponsor
- University of Milan
- Brief Summary
Surgical resection in patients with multiple hepatocellular carcinomas (HCC) remains controversial. The aim of this study was to investigate the outcome of a consecutive cohort of patients resected for multiple HCC, without macrovascular invasion, in order to identify clinically reliable parameters to select patients for surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 87
- patients with multiple HCC without macrovascular invasion on liver cirrhosis
- macrovascular invasion;
- normal liver;
- distant or lymphnodes metastasis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Overall survival plus multivariate analysis 10 years The primary endpoint of the study was the overall survival of patients resected for multiple HCC, and the univariate and multivariate analyses of prognostic factors for overall survival.
- Secondary Outcome Measures
Name Time Method Disease-free survival 10 years The secondary endpoint was the disease-free survival.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Milan IRCCS Istituto Clinico Humanitas
🇮🇹Rozzano, Milan, MI, Italy
University of Milan IRCCS Istituto Clinico Humanitas🇮🇹Rozzano, Milan, MI, Italy